Primary |
Infertility |
32.3% |
In Vitro Fertilisation |
26.9% |
Product Used For Unknown Indication |
11.5% |
Ovulation Induction |
10.0% |
Assisted Fertilisation |
6.2% |
Drug Use For Unknown Indication |
4.6% |
Infertility Female |
3.8% |
Vitamin Supplementation |
1.5% |
Anovulatory Cycle |
0.8% |
Jugular Vein Thrombosis |
0.8% |
Ovarian Hyperstimulation Syndrome |
0.8% |
Therapeutic Procedure |
0.8% |
|
Ovarian Hyperstimulation Syndrome |
29.3% |
Abortion Spontaneous |
7.3% |
Maternal Drugs Affecting Foetus |
7.3% |
Pregnancy |
7.3% |
Dyspnoea |
4.9% |
Mydriasis |
4.9% |
Somnolence |
4.9% |
Weight Decreased |
4.9% |
Abdominal Discomfort |
2.4% |
Abdominal Distension |
2.4% |
Breast Cancer Female |
2.4% |
Cyst |
2.4% |
Cystosarcoma Phyllodes |
2.4% |
Drug Ineffective |
2.4% |
Dyspnoea Exertional |
2.4% |
Exposure During Pregnancy |
2.4% |
Extrasystoles |
2.4% |
Fatigue |
2.4% |
Gait Disturbance |
2.4% |
Headache |
2.4% |
|
Secondary |
In Vitro Fertilisation |
33.6% |
Product Used For Unknown Indication |
20.6% |
Infertility |
13.4% |
Ovulation Induction |
11.3% |
Infertility Female |
3.4% |
Ovarian Hyperstimulation Syndrome |
3.4% |
Assisted Fertilisation |
2.5% |
Drug Use For Unknown Indication |
1.7% |
Hypertension |
1.7% |
Infertility Male |
1.7% |
Ovarian Disorder |
1.3% |
Coagulopathy |
0.8% |
Hormone Suppression Therapy |
0.8% |
Ovarian Failure |
0.8% |
Prophylaxis |
0.8% |
Angiopathy |
0.4% |
Anovulatory Cycle |
0.4% |
Drug Therapy |
0.4% |
Growth Hormone Deficiency |
0.4% |
Nausea |
0.4% |
|
Deep Vein Thrombosis |
9.4% |
Ovarian Hyperstimulation Syndrome |
9.4% |
Abdominal Pain |
7.5% |
Weight Decreased |
7.5% |
Oesophageal Ulcer |
5.7% |
Pulmonary Mass |
5.7% |
Tremor |
5.7% |
Abdominal Distension |
3.8% |
Abortion Spontaneous |
3.8% |
Cerebrovascular Accident |
3.8% |
Drug Ineffective |
3.8% |
Eosinophilic Pneumonia Acute |
3.8% |
No Therapeutic Response |
3.8% |
Pleural Effusion |
3.8% |
Pregnancy |
3.8% |
Thrombocytosis |
3.8% |
Thyroiditis |
3.8% |
Visual Acuity Reduced |
3.8% |
Vomiting |
3.8% |
White Blood Cell Count Increased |
3.8% |
|
Concomitant |
Product Used For Unknown Indication |
42.0% |
In Vitro Fertilisation |
30.7% |
Infertility |
3.4% |
Ovulation Induction |
2.9% |
Artificial Insemination By Partner |
2.5% |
Assisted Fertilisation |
2.5% |
Supplementation Therapy |
2.5% |
Vitamin Supplementation |
1.7% |
Contraception |
1.3% |
Drug Use For Unknown Indication |
1.3% |
Thyroid Disorder |
1.3% |
Vitamin D Deficiency |
1.3% |
Blood Follicle Stimulating Hormone |
0.8% |
Blood Follicle Stimulating Hormone Abnormal |
0.8% |
Hypopituitarism |
0.8% |
Irritable Bowel Syndrome |
0.8% |
Mineral Supplementation |
0.8% |
Oestrogen Replacement Therapy |
0.8% |
Oocyte Harvest |
0.8% |
Ovarian Hyperstimulation Syndrome |
0.8% |
|
Headache |
13.3% |
Drug Exposure During Pregnancy |
8.9% |
Rash |
8.9% |
Ovarian Disorder |
6.7% |
Ovarian Hyperstimulation Syndrome |
6.7% |
Antepartum Haemorrhage |
4.4% |
Diplopia |
4.4% |
Drug Ineffective |
4.4% |
Hot Flush |
4.4% |
Incorrect Dose Administered By Device |
4.4% |
Infertility Female |
4.4% |
Injection Site Pain |
4.4% |
Malaise |
4.4% |
Mood Swings |
4.4% |
Tremor |
4.4% |
Abdominal Distension |
2.2% |
Abortion Missed |
2.2% |
Abortion Spontaneous |
2.2% |
Bile Duct Stone |
2.2% |
Contraindication To Medical Treatment |
2.2% |
|
Interacting |
In Vitro Fertilisation |
100.0% |
|
Ovarian Hyperstimulation Syndrome |
100.0% |
|